Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory disease of the mucous membranes of the nose and paranasal sinuses. Eosinophilic inflammation is described as a common endotype. The anti-interleukin-5 (IL-5) antibody mepolizumab was approved in November 2021 as an ad...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ludger Klimek, Ulrike Förster-Ruhrmann, Heidi Olze, Achim G. Beule, Adam M. Chaker, Jan Hagemann, Tilmann Huppertz, Thomas K. Hoffmann, Stefan Dazert, Thomas Deitmer, Sebastian Strieth, Holger Wrede, Wolfgang Schlenter, Hans-Jürgen Welkoborsky, Barbara Wollenberg, Sven Becker, Frederike Bärhold, Felix Klimek, Ingrid Casper, Jaron Zuberbier, Claudia Rudack, Mandy Cuevas, Constantin A. Hintschich, Orlando Guntinas-Lichius, Timo Stöver, Christoph Bergmann, Pascal Werminghaus, Oliver Pfaar, Jan Gosepath, Moritz Gröger, Caroline Beutner, Martin Laudien, Rainer K. Weber, Tanja Hildenbrand, Anna-Sophie Hoffmann, Claus Bachert
Formato:	Artigo
Idioma:	Inglês
Publicado:	Open Exploration Publishing Inc. 2024-02-01
Series:	Exploration of Asthma & Allergy
Assuntos:	chronic rhinosinusitis chronic rhinosinusitis with nasal polyps biologics eosinophilic inflammation mepolizumab
Acceso en liña:	https://www.explorationpub.com/uploads/Article/A100927/100927.pdf
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!